Share on LinkedInShare on LinkedIn

ARTICLE · 11 JANUARY 2023

Why Broad Functional Patent Claims Suppress Medical Innovation

Herbert Smith Freehills Kramer LLP
Herbert Smith Freehills Kramer LLP
Contributor
Herbert Smith Freehills Kramer LLP

Herbert Smith Freehills Kramer LLP

We have one of the largest Southeast Asia international law practices, working across the region...

View firm profile
Explore more from Herbert Smith Freehills Kramer LLP

Head of Life Sciences Irena Royzman authored a Bloomberg Law article titled "Why Broad Functional Patent Claims Suppress Medical Innovation" on Jan. 9, 2023.

United StatesIntellectual Property

Head of Life Sciences Irena Royzman authored a Bloomberg Law article titled "Why Broad Functional Patent Claims Suppress Medical Innovation" on Jan. 9, 2023. The article analyzes broad functional patent claims of biologic materials and how a current US Supreme Court case could have a major impact on drug development and other areas of innovation.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from